Azenta Announces Earnings Call for Q1 2026
Azenta, Inc. (Nasdaq: AZTA), a prominent player in the life sciences solutions sector, is set to reveal its fiscal first quarter earnings for 2026, which concluded on December 31, 2025. This announcement will be made on February 4, 2026, just before the market opens.
The company invites analysts, investors, and media representatives to join a conference call and live webcast on the same day at 8:30 a.m. Eastern Time to discuss these financial results. This approach provides all stakeholders with the opportunity to gain insights into the company’s performance and strategy.
Accessing the Live Webcast
Participants can easily access the live webcast through Azenta's official website. This engaging format allows for real-time interaction and insight into the company’s accomplishments during the first quarter. Given the importance of these earnings, the event is anticipated to attract significant interest among investors and industry analysts.
Replay Information
A recorded version of the conference call will be available for those who cannot attend the live session. The replay will commence at 8:30 a.m. ET on February 5, 2026, ensuring that all interested parties can follow up on key insights and highlights shared during the call.
About Azenta, Inc.
Azenta, Inc. stands out as a leading provider of life sciences solutions on a global scale, dedicated to driving impactful breakthroughs and expediting therapies to market. The company offers a comprehensive suite of reliable cold-chain sample management solutions and multiomics services that cater to critical sectors such as drug development and clinical research.
Industry Influence
Azenta’s clientele includes some of the most prestigious pharmaceutical, biotech, academic, and healthcare institutions worldwide. The diverse range of services is delivered through renowned brands such as GENEWIZ, FluidX, and Barkey, reflecting Azenta's commitment to excellence in life sciences.
Global Operations
Headquartered in Burlington, Mass., Azenta operates across North America, Europe, and Asia. This global reach positions Azenta to effectively meet the needs of its international clientele while maintaining high standards of service delivery and innovation.
Contact Information
For any inquiries, investors can reach out to:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
Maria Isabel Cuartas
Manager of Investor Relations
Frequently Asked Questions
When is Azenta's Q1 earnings announcement?
Azenta will announce its Q1 2026 earnings on February 4, 2026.
How can I access the earnings call?
The earnings call can be accessed via live webcast on Azenta's website.
Is there a replay available for the earnings call?
Yes, a replay will be available starting on February 5, 2026, at 8:30 a.m. ET.
What services does Azenta provide?
Azenta provides cold-chain sample management solutions and multiomics services for drug development and clinical research.
Where is Azenta located?
Azenta is headquartered in Burlington, Massachusetts, with operations worldwide.